A Drug-Drug Interaction Study of Lanabecestat (LY3314814) in Healthy Participants
Clinical trial NCT02406261 · COMPLETED
Trial details
- NCT number
- NCT02406261
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-04-30
- Primary completion
- 2015-08-31
- Enrollment
- 82
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.